- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
TheminorcapsidproteinL2isapromisingcandidatefortheconstructionofananti
The minor capsid protein L2 is a promising candidate for the construction of an anti-human papillomavirus (HPV) broadly protective vaccine for the prophylaxis of cervical cancer.
However, L2-derived peptides are usually poorly immunogenic and extensive knowledge on the most relevant(cross)neutralizing epitope(s) is still needed.
We systematically examined the immunogenicity and Virus neutralization potential of six peptides encompassing the N-terminal (amino acids 1-120) region of HPV16 L2 (20-38; 28-42; 56-75: 64-81; 96-115; 108-120) using bacterial thioredoxin (Trx) as a novel peptide scaffold.
Mice antisera generated by 19 different Trx-L2 peptide fusions hearing one or multiple copies of each peptide were analyzed.
Internal fusion to thioredoxin conferred strong immunogenicity to all the tested peptides, with a trend toward art increased immunogenicity for the multipeptide vs. the monopeptide forms of the various antigens. All Trx-L2 peptides induced HPV16 neutralizing antibodies in some of the immunized mice, but neutralization titers differed by more than two orders of magnitude. Trx-L2(20-38) antisera were by far the most effective in HPV16 neutralization and did not differ significantly from those induced by a reference polypeptide covering the entire L2 (1-120) region. The same antisera were also the most effective when challenged against the non-cognate HPV 18, 58, 45 and 31 pseudovirions.
The data identify L2(20-38) as the best (cross)neutralizing epitope among the six that were examined, and point to thioredoxin fusion derivatives of this peptide as excellent candidates for the formulation of a low-cost, broadly protective HPV vaccine. (C) 2009 Elsevier Ltd. All rights reserved.
人乳头瘤病毒L2蛋白N末端肽片段与硫氧还原蛋白偶联在体内引起抗多肽片段的抗体,其中L2(20-38)肽段引起抗体作用最强,可能用于 制造低价的抗人乳头瘤病毒疫苗。
Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20-38) peptide displayed on bacterial thioredoxin
Vaccine science hits extended beyond genomics to prote
文档评论(0)